S1041 Treatment Patterns of an Adalimumab Biosimilar (ABP 501) Among Patients With Inflammatory Bowel Disease: An Observational Study Using German Pharmacy Claims Database. (October 2022) - Kruppert, Silvia; Hammer, Marc; O'Kelly, James; Scholz, Florian; Kricorian, Greg; Reinisch, Walter